Form 4: Merck Director Lavizzo-Mourey Reports Transaction in Company Stock

Director Risa Lavizzo-Mourey reports a transaction involving Merck & Co., Inc. common stock and phantom stock units.

Summary

• On May 31, 2024, Risa Lavizzo-Mourey, a director of Merck & Co., Inc., reported a transaction involving the company's securities.
• The transaction included the disposal of 1,000 shares of common stock.
• Lavizzo-Mourey also acquired 1,752.4295 units of phantom stock at a price of $125.54.
• Following the reported transactions, Lavizzo-Mourey beneficially owns 12,120.4279 shares of common stock, including shares acquired through dividend reinvestment transactions.
• The phantom stock units are to be settled 100% in cash upon the director's termination of service, according to a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a transaction by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, according to a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.

Industry Context

This filing is a routine disclosure of a transaction by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel within Merck.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the trading activities of a company director.

Key Dates